Exploring heterogeneities of cardiovascular efficacy and effectiveness of SGLT2 inhibitors in patients with type 2 diabetes: an umbrella review of evidence from randomized clinical trials versus real-world observational studies Bojung SeoJialin SuYiqing Song Review 07 June 2022 Pages: 1205 - 1216
Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review Shu HuangSeonkyeong YangKhoa Anh Nguyen Review 03 June 2022 Pages: 1217 - 1225
Meta-analysis of the associations of IMPDH and UGT1A9 polymorphisms with rejection in kidney transplant recipients taking mycophenolic acid Lin ChengPu YaoQian Wang Pharmacodynamics 07 May 2022 Pages: 1227 - 1238
Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib Akimitsu MaedaHitoshi AndoMasataka Sawaki Pharmacogenetics 09 May 2022 Pages: 1239 - 1247
Association study identifies genetic determinants and non-genetic factors on steady-state plasma and therapeutic outcome of galantamine in mixed dementia Thitipon YaowalukVorapun SenanarongPornpimol Kijsanayotin Pharmacogenetics 28 May 2022 Pages: 1249 - 1259
The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients Xi-Han WangKun ShaoBing Chen Pharmacokinetics and Disposition 10 May 2022 Pages: 1261 - 1272
Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients M. I. FranckeW. J. VisserB. C. M. De Winter Pharmacokinetics and Disposition Open access 14 May 2022 Pages: 1273 - 1287
Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range Kine Eide KvitneKristine HoleIda Robertsen Pharmacokinetics and Disposition Open access 01 June 2022 Pages: 1289 - 1299
Applying pharmacokinetic/pharmacodynamic measurements for linezolid in critically ill patients: optimizing efficacy and reducing resistance occurrence Rasha M. El-GamlNoha M. El-KhodarySoha M. El-Masry Pharmacokinetics and Disposition Open access 25 May 2022 Pages: 1301 - 1310
Stereoselective interaction of tolvaptan with amiodarone under racemic metabolic impact by CYP3A5 genotypes in heart failure patients Shunta AkutsuYasuaki MinoJunichi Kawakami Pharmacokinetics and Disposition 23 May 2022 Pages: 1311 - 1320
Role of ADME gene polymorphisms on imatinib disposition: results from a population pharmacokinetic study in chronic myeloid leukaemia Bharati ShriyanParsshava MehtaVikram Gota Pharmacokinetics and Disposition 02 June 2022 Pages: 1321 - 1330
Clinical relevance of potentially inappropriate medications and potential prescribing omissions according to explicit criteria—a validation study Naldy Parodi LópezStaffan A. SvenssonSusanna M. Wallerstedt Pharmacoepidemiology and Prescription Open access 01 June 2022 Pages: 1331 - 1339
Incidence of hospital contacts with acute kidney injury after initiation of second-generation antipsychotics in older adults: a Danish population-based cohort study Reeha SharonTheis LangeMorten Andersen Pharmacoepidemiology and Prescription Open access 31 May 2022 Pages: 1341 - 1349
Non-peer-reviewed data, effect measures, and meta-regression analysis on proton pump inhibitor use and COVID-19 Dan-Na WuLi-Rong JiaoGuo Yu Letter to the Editor 16 May 2022 Pages: 1351 - 1352
Authors’ reply to the letter to editor “Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis” Hong-Bae KimJung-Ha KimBethany J. Wolf Letter to the Editor 16 May 2022 Pages: 1353 - 1354
Sex differences in serious adverse drug reactions in patients receiving immunotherapy, targeted therapy, or chemotherapy: a disproportionality analysis of the VigiBase® Guillaume WabontSandrine BergeronRomain Barus Letter to the Editor 13 May 2022 Pages: 1355 - 1356
A rare side effect due to voriconazole: myasthenia gravis Fusun Zeynep AkcamBetul Nur BacanakVedat Ali Yurekli Letter to the Editor 03 June 2022 Pages: 1357 - 1359
Correction to: Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis Hong-Bae KimJung-Ha KimBethany J. Wolf Correction 17 May 2022 Pages: 1361 - 1361
Correction to: Prevalence and patient‑rated relevance of complexity factors in medication regimens of community dwelling patients with polypharmacy Viktoria S. WurmbachSteffen J. SchmidtHanna M. Seidling Correction Open access 02 June 2022 Pages: 1363 - 1363